Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Alibaba Health Information Technology with a HK$5.33 average price target.
Based on Alibaba Health Information Technology’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of HK$16.59 billion and a net profit of HK$1.26 billion. In comparison, last year the company earned a revenue of HK$7.14 billion and had a net profit of HK$384.48 million
